In addition, icariside II was proved to reduce the level of STAT3 in MDA-MB-231 (breast adenocarcinoma) and DU145 (prostate carcinoma) cells, in which STAT3 is constitutively active [57]. The gene discussed is STAT3; the disease is prostate carcinoma.